Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study.
Juthaporn CowanVincent R BonaguraPatricia L LugarPaul J MaglioneNiraj C PatelDonald C VinhJutta H HofmannMichaela PrausMikhail A RojavinPublished in: Journal of clinical immunology (2020)
NCT03033745.